Influence of Co-morbidity on Mortality and Morbidity in Patients Treated With Hemodialysis

American Journal of Kidney Diseases

Volumn 24, Issue 6, 1994, Pages 1010-1018

  Keane, William F ^a   Collins, Allan J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

co morbidity; Hemodialysis; morbidity; mortality; risk factors

Indexed keywords

CANCER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; HEART DISEASE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MORBIDITY; MORTALITY; PARAPROTEINEMIA; PERIPHERAL VASCULAR DISEASE; TREATMENT OUTCOME;

EID: 0027962377     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)81076-6     Document Type: Article

References (32)

1. Proceedings from the Morbidity, Mortality and Prescription of Dialysis Symposium
2. Results of renal replacement therapy in Europe, 1980 to 1987
3. Results from the Canadian Renal Failure Registry
4. Dialysis treatment in Australia, 1982 to 1988
5. Mortality rates among dialysis patients in Medicare's end-stage renal disease program
6. Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality
7. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987
8. Adequacy of hemodialysis
9. Risk factors in hemodialysis patient survival
10. The clinical evaluation of chemotherapeutic agents in cancer
11. Urea index and other predictors of hemodialysis patient survival
12. Congestive heart failure in dialysis patients
13. The epidemiology of coronary artery disease in patients on maintenance hemodialysis: Implications for management
14. Left ventricular hypertrophy in end-stage renal disease
15. Impact of left ventricular hypertrophy on survival in endstage renal disease
16. Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients
17. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients
18. Commonly measured laboratory variables in hemodialysis patients: Relationships among them and death risk
19. Infectious and all-cause death rates in hemodialysis (HD) patients (PTS) are lower with a mean hematocrit (HCT) of 32% versus 26%
20. Contribution of vascular access-related disease to morbidity of hemodialysis patients
21. Diabetic hemodialysis patients treated with a high Kt/V have a lower risk of death than standard Kt/V
22. High-efficiency bicarbonate hemodialysis has a lower risk of death than standard acetate dialysis
23. Comparison of hemodialysis survival in USRDS patients versus Regional Kidney Disease Program patients
24. Hemodialysis prescription and delivery in the US: Results from USRDS case mix study
25. Evaluation of initial predictors of mortality among 4387 new ESRD patients: The USRDS case mix study
26. Survival as an index of adequacy of dialysis
27. Increasing dose of dialysis improves mortality and nutritional parameters in hemodialysis (HD) patients
28. Mortality in chronic dialysis patients in Japan